Skip to main content
VCbacked
Log inGet Started

Vivace Therapeutics

San Mateo, United States

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

$35.0M raised
Mar 2025
Series D
BiotechnologyHealth CareMedicalTherapeutics

Top Investors

Sequoia CapitalRA Capital ManagementCanaan PartnersMission BioCapitalMission Bay Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vivace Therapeutics

How much funding has Vivace Therapeutics raised?
Vivace Therapeutics has raised $35.0M in total funding. The most recent round was Series D. The last funding was announced in March 2025.
Who are Vivace Therapeutics's investors?
Vivace Therapeutics's investors include Sequoia Capital, RA Capital Management, Canaan Partners, Mission BioCapital, Mission Bay Capital.
Where is Vivace Therapeutics headquartered?
Vivace Therapeutics is headquartered in San Mateo, United States.
What does Vivace Therapeutics do?
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.
What stage is Vivace Therapeutics at?
Vivace Therapeutics is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Vivace Therapeutics — Funding & Investors." VCBacked, March 12, 2025, https://www.vcbacked.co/company/vivace-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2025). Vivace Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/vivace-therapeutics
Wikipedia (cite web)
{{cite web |title=Vivace Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/vivace-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong